Latest News for: bcg

Edit

Middle East M&A Activity Surges 260% Despite Market Volatility, Driven by Strategic Diversification and Digital Transformation

bizbahrain 23 Dec 2025
This exceptional growth comes despite experiencing its lowest levels since the COVID shock earlier in the year, according to BCG’s annual Global M&A Report 2025 released today ... BCG’s M&A ...
Edit

Aadhaar, digital payments cut India's welfare leakage by 13%: BCG Report

The Times of India 22 Dec 2025
India has significantly cut welfare system leakage by almost 13 percent ... .
Edit

Middle East M&A deal values surge 260% to $53bn in first nine months of 2025: BCG

Gulf-Times 22 Dec 2025
This exceptional growth comes despite experiencing its lowest levels since the Covid shock earlier in the year, according to BCG's annual Global M&A Report 2025 released Monday ... BCG's M&A Sentiment ...
Edit

From McKinsey to PwC, here's how elite consulting firms are racing to hire engineers — ...

Business Insider 19 Dec 2025
BCG, which brought on 1,000 employees last year, has ramped up hiring technologists since launching its tech and AI arm, BCG X, in late 2022 ... firm," said Sylvain Duranton, Global Leader of BCG X.
Edit

UAE wealth tops $3.12tn in 2024 as assets surge, shows BCG report

Gulf Business 18 Dec 2025
The report also revealed that investable wealth is projected to grow from $942bn in 2024 to $1.34tn by 2029, with a 7.2 per cent CAGR ... .
Edit

Bahrain’s Net Wealth Hits Record-High, Reaching $160 Billion in 2024

bizbahrain 17 Dec 2025
The key Bahrain findings of BCG’s new proprietary analysis are. ... wealth managers lies in their ability to seize these opportunities,” added Lukasz Rey, Managing Director and Partner at BCG.
Edit

ANKTIVA� with BCG Demonstrates 96% Survival from Bladder Cancer at Three Years with Median Survival ...

Business Wire 16 Dec 2025
... in patients with BCG-unresponsive high-grade papillary-only non-muscle invasive bladder cancer .
Edit

ANKTIVA® with BCG Demonstrates 96% Survival from Bladder Cancer at Three Years with Median Survival Not Yet Reached in BCG-Unresponsive High-Grade Papillary-Only Non-Muscle Invasive Bladder Cancer

Pharmiweb 16 Dec 2025
QUILT-3.032 (NCT03022825) is a registrational, open-label, single-arm multicenter phase 2/3 trial of ANKTIVA plus BCG in patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC).
Edit

UAE Wealth Surge: Net Worth Hits $3.12 Trillion, BCG Report Reveals

Gulf News 16 Dec 2025
Lukasz Rey, Managing Director and Partner at BCG, said, “The key to success today is no longer merely about gaining market exposure or hiring senior bankers; it’s about fostering internal growth.
×